HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ErbB-4 ribozymes abolish neuregulin-induced mitogenesis.

Abstract
The epidermal growth factor-like receptor tyrosine kinase (ErbB) family is frequently overexpressed in a variety of human carcinomas, including breast cancer. To assist in characterizing the role of ErbB-4 in breast cancer, we generated three specific hammerhead ribozymes targeted to the ErbB-4 mRNA. These ribozymes, Rz6, Rz21, and Rz29, efficiently catalyzed the specific cleavage of ErbB-4 message in a cell-free system. We demonstrated that the neuregulin-induced mitogenic effect was abolished in ribozyme Rz29- and Rz6-transfected 32D/ErbB-4 cells. Inhibition of mitogenesis was characterized by ribozyme-mediated down-regulation of ErbB-4 expression. In addition, we provide the first evidence that different threshold levels of ErbB-4 expression and activation correlate with different responses to neuregulin stimulation. High levels of ErbB-4 expression, phosphorylation, and homodimerization are necessary for neuregulin-stimulated, interleukin 3-independent cell proliferation in the 32D/E4 cells. In the case of Rz29-transfected 32D/E4 cells, low levels of ErbB-4 expression allowed neuregulin-induced phosphorylation but were insufficient to couple the activated receptor to cellular signaling. Furthermore, expression of the functional ErbB-4 ribozyme in T47D human breast carcinoma cells led to a down-regulation of endogenous ErbB-4 expression and a reduction of anchorage-independent colony formation. These studies support the use of ErbB-4 ribozymes to define the role of ErbB-4 receptors in human cancers.
AuthorsC K Tang, D J Goldstein, J Payne, F Czubayko, M Alimandi, L M Wang, J H Pierce, M E Lippman
JournalCancer research (Cancer Res) Vol. 58 Issue 15 Pg. 3415-22 (Aug 01 1998) ISSN: 0008-5472 [Print] United States
PMID9699674 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Glycoproteins
  • Interleukin-3
  • Neuregulins
  • RNA, Catalytic
  • RNA, Messenger
  • DNA
  • ERBB4 protein, human
  • ErbB Receptors
  • Erbb4 protein, mouse
  • Receptor, ErbB-4
Topics
  • Animals
  • Breast Neoplasms (enzymology, metabolism, pathology)
  • Cell Division (drug effects, physiology)
  • Cell-Free System
  • Cells, Cultured
  • DNA (biosynthesis)
  • Down-Regulation
  • ErbB Receptors (biosynthesis, metabolism, physiology)
  • Glycoproteins (pharmacology)
  • Hematopoietic System (cytology, enzymology)
  • Humans
  • Interleukin-3 (pharmacology)
  • Mice
  • Neuregulins
  • Phosphorylation
  • RNA, Catalytic (metabolism, pharmacology)
  • RNA, Messenger (metabolism)
  • Receptor, ErbB-4
  • Stimulation, Chemical
  • Substrate Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: